FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

8176111000001108: Bupivacaine hydrochloride anhydrous (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
14789501000001111 Bupivacaine hydrochloride anhydrous (substance) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
14789601000001110 Bupivacaine hydrochloride anhydrous en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bupivacaine hydrochloride anhydrous Is a Bupivacaine hydrochloride true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Bupivacaine 12.5mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules Has active ingredient False Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Bupivacaine 50mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection ampoules Has active ingredient False Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Bupivacaine 25mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules Has active ingredient False Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Bupivacaine 100mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,00) solution for injection ampoules Has active ingredient False Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.25% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) Has active ingredient False Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.25% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) Has active ingredient False Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.5% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) Has active ingredient False Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.5% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) Has active ingredient False Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Bupivacaine 12.5mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules 1 ampoule Has active ingredient False Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Bupivacaine 50mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection ampoules 1 ampoule Has active ingredient False Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Bupivacaine 25mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules 1 ampoule Has active ingredient False Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Bupivacaine 100mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,00) solution for injection ampoules 1 ampoule Has active ingredient False Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.25% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule Has active ingredient False Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.25% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule Has active ingredient False Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.5% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule Has active ingredient False Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.5% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule Has active ingredient False Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.5% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Bupivacaine 100mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,00) solution for injection ampoules Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.5% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Bupivacaine 100mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,00) solution for injection ampoules 1 ampoule Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.5% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Bupivacaine 25mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules 1 ampoule Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.5% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Bupivacaine 25mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.25% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.25% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Bupivacaine 50mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection ampoules 1 ampoule Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Bupivacaine 50mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection ampoules Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Bupivacaine 12.5mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Bupivacaine 12.5mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules 1 ampoule Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.25% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Carbostesin-adrenaline 0.25% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Bupivacaine 200mg/5ml (4%) solution for injection ampoules Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Bupivacain Sintetica 40mg/ml (4%) solution for injection ampoules (Imported (Switzerland)) Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Bupivacaine 200mg/5ml (4%) solution for injection ampoules 10 ampoule Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier
Bupivacain Sintetica 40mg/ml (4%) solution for injection ampoules (Imported (Switzerland)) 10 ampoule Has specific active ingredient True Bupivacaine hydrochloride anhydrous Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start